Steiger C, Phan N, Sun H, Huang H, Hess K, Lopes A
Clin Transl Gastroenterol. 2021; 11(12):e00229.
PMID: 33512801
PMC: 7710212.
DOI: 10.14309/ctg.0000000000000229.
Metz P, Tjan M, Wu S, Pervaiz M, Hermans S, Shettigar A
Front Cell Infect Microbiol. 2019; 9:364.
PMID: 31709196
PMC: 6823872.
DOI: 10.3389/fcimb.2019.00364.
Izzy M, Malieckal A, Little E, Anand S
World J Gastrointest Pharmacol Ther. 2016; 7(2):334-42.
PMID: 27158549
PMC: 4848256.
DOI: 10.4292/wjgpt.v7.i2.334.
Lazaraki G, Chatzimavroudis G, Katsinelos P
World J Gastroenterol. 2014; 20(27):8867-85.
PMID: 25083060
PMC: 4112893.
DOI: 10.3748/wjg.v20.i27.8867.
Eswaran S, Guentner A, Chey W
J Neurogastroenterol Motil. 2014; 20(2):141-51.
PMID: 24840367
PMC: 4015201.
DOI: 10.5056/jnm.2014.20.2.141.
Chronic constipation: new diagnostic and treatment approaches.
Lacy B, Levenick J, Crowell M
Therap Adv Gastroenterol. 2012; 5(4):233-47.
PMID: 22778789
PMC: 3388525.
DOI: 10.1177/1756283X12443093.
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
Rao A, Wong B, Camilleri M, Odunsi-Shiyanbade S, McKinzie S, Ryks M
Gastroenterology. 2010; 139(5):1549-58, 1558.e1.
PMID: 20691689
PMC: 3189402.
DOI: 10.1053/j.gastro.2010.07.052.
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.
Odunsi-Shiyanbade S, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio I
Clin Gastroenterol Hepatol. 2009; 8(2):159-65.
PMID: 19879973
PMC: 2822105.
DOI: 10.1016/j.cgh.2009.10.020.
Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents.
Mikov M, Fawcett J, Kuhajda K, Kevresan S
Eur J Drug Metab Pharmacokinet. 2006; 31(3):237-51.
PMID: 17136862
DOI: 10.1007/BF03190714.
Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?.
Pereira S, Hussaini S, Kennedy C, Dowling R
Dig Dis Sci. 1995; 40(12):2568-75.
PMID: 8536514
DOI: 10.1007/BF02220443.
Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.
Hood K, Gleeson D, Ruppin D, Dowling R
Gut. 1993; 34(9):1277-88.
PMID: 8406169
PMC: 1375471.
DOI: 10.1136/gut.34.9.1277.
Pharmacological treatment of gallstones. Practical guidelines.
Lanzini A, Northfield T
Drugs. 1994; 47(3):458-70.
PMID: 7514975
DOI: 10.2165/00003495-199447030-00006.
Gallstone dissolution with chenodeoxycholic acid. A clinical study.
Weis H, Holtermuller K, Gilsdorf P
Klin Wochenschr. 1980; 58(6):313-20.
PMID: 7374101
DOI: 10.1007/BF01476574.
Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith T, Williams G, Maton P, Murphy G, SAXTON H, Dowling R
Gut. 1982; 23(5):382-9.
PMID: 7076015
PMC: 1419686.
DOI: 10.1136/gut.23.5.382.
Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
Maudgal D, Kupfer R, Northfield T
Gut. 1982; 23(4):280-4.
PMID: 7076005
PMC: 1419743.
DOI: 10.1136/gut.23.4.280.
Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey.
Bazzoli F, Roda A, Fromm H, Sarva R, Roda E, Barbara L
Dig Dis Sci. 1982; 27(5):417-24.
PMID: 7075428
DOI: 10.1007/BF01295650.
Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
Iser J, Sali A
Drugs. 1981; 21(2):90-119.
PMID: 7009140
DOI: 10.2165/00003495-198121020-00002.
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation.
Ellis W, Somerville K, Whitten B, Bell G
Br Med J (Clin Res Ed). 1984; 289(6438):153-6.
PMID: 6430390
PMC: 1442019.
DOI: 10.1136/bmj.289.6438.153.
Medical aspects of gallstones--1985: sixty years on.
Dowling R, Gleeson D
Postgrad Med J. 1985; 61(720):875-86.
PMID: 3903715
PMC: 2418286.
DOI: 10.1136/pgmj.61.720.875.
Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.
ODONNELL L, Heaton K
Gut. 1988; 29(5):655-8.
PMID: 3396952
PMC: 1433655.
DOI: 10.1136/gut.29.5.655.
